Global Primary Immunodeficiency Therapeutics Market Is Expected To Reach $ 11.1 Billion By 2030 - An Exclusive Market Research Report By Lucintel

By Author: Lucintel LLC
Total Articles: 5909
Comment this article

Lucintel's latest study found that, The future of the global primary immunodeficiency therapeutics market looks promising with opportunities in the immunoglobulin replacement therapy, stem cell/bone marrow transplantation, antibiotic therapy, and gene therapy markets. The global primary immunodeficiency therapeutics market is expected to reach an estimated $11.1 billion by 2030 with a CAGR of 6.3% from 2024 to 2030. The major drivers for this market are increasing primary immunodeficiency disorders awareness, rising genomic research, and on-going advancement in diagnostoc technologies, such as genetic testing, flow cytometry, and next-generation sequencing.
In this market, antibody deficiency, cellular immunodeficiency, and innate immune disorders are the major segments of primary immunodeficiency therapeutics market by disease type.
Lucintel forecasts that antibody deficiency will remain the largest segment due to increasing awareness of antibody deficiency and aging population is more susceptible to antibody deficiency.
Browse in depth TOC of the Primary Immunodeficiency Therapeutics Market:
100 - Figures
...
... 150-Pages
Primary Immunodeficiency Therapeutics Market is marked by presence of several big and small players. Pfizer, CSL Behring, Grifols, Abbott, Adma Biologics, Astrazeneca, Baxter, Bayer, Biocon, and Bristol-Myers Squibb are the major suppliers in the primary immunodeficiency therapeutics market.
This unique research report will enable you to make confident business decisions in this globally competitive marketplace. For a detailed table of contents, contact Lucintel at +1-972-636-5056 or click on this link helpdesk@lucintel.com.
About Lucintel
Lucintel, the premier global management consulting and market research firm, creates winning strategies for growth. It offers market assessments, competitive analysis, opportunity analysis, growth consulting, M&A, and due diligence services to executives and key decision-makers in a variety of industries.
Contact:
Roy Almaguer
Lucintel
Dallas, Texas, USA
Email: roy.almaguer@lucintel.com
Tel. 972.636.5056
Related Reports
1. Pharmaceutical Contract Manufacturing Market

2. Medical Battery Market

3. Stent Market

4. Wheelchair Market

5. 3D Printing Medical Device Market

6. Medical Device Market

7. Diagnostic Imaging Market

8. Medical Lifting Sling Market

9. Liquid Biopsy Market

10. Stretcher Market